[This retracts the article DOI: 10.1155/2014/947606.].
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9750764 | PMC |
| http://dx.doi.org/10.1155/2022/9854346 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Predicting Immune Checkpoint Inhibitor-Related Pneumonitis via Computed Tomography and Whole-Lung Analysis Deep Learning.
Curr Med Imaging
November 2024
Department of Respiratory and Critical Care Medicine, Air Force Medical Center, Beijing, China.
Background: Immune checkpoint inhibitor-related pneumonitis (ICI-P) is a fatal adverse event of immunotherapy. However, there is a lack of methods to identify patients who have a high risk of developing ICI-P in immunotherapy.
Purpose: We aim at predicting the individualized risk of developing ICI-P by computed tomography (CT) images and deep learning to assist in personalized immunotherapy planning.
A pathological complete response to capecitabine plus oxaliplatin regimen combined with tislelizumab in advanced gastric cancer with liver metastases: A case report.
Hum Vaccin Immunother
December 2024
Department of Gastroenterology, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, China.
Article Synopsis
- * She underwent a combination of chemotherapy and immunotherapy, specifically the XELOX regimen with tislelizumab, leading to the complete disappearance of liver metastases and significant shrinkage of the primary tumor.
- * Following a successful laparoscopy and radical total gastrectomy, which showed no remaining cancer, the patient now receives ongoing treatment to address any potential residual disease, showcasing the effectiveness of combining immunotherapy with traditional chemotherapy in advanced cancer cases.
When Uveitis and Hypotony Meets Bilateral Iris Retraction Syndrome: A Rare but Serious Complication of Nivolumab Treatment.
Case Rep Ophthalmol
July 2024
1st Ophthalmology Department, "G. Gennimatas" Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Introduction: Iris retraction syndrome (IRS) is a rare clinical condition characterized by a backbowing of the iris positioned on the lens with a complete pupillary block. Immune checkpoint inhibitors (ICIs) are a new class of immunomodulating agents used in cancer therapy, and although they have high response rates, ophthalmic-related side effects have been reported. We report a rare case of bilateral IRS with hypotony after therapy with nivolumab.
View Article and Find Full Text PDFRetraction Note: Autoantibodies detection in patients affected by autoimmune retinopathies.
Eur Rev Med Pharmacol Sci
May 2024
Department of Pharmaceutical Sciences, University of Perugia, Perugia, Italy.
The article "Autoantibodies detection in patients affected by autoimmune retinopathies", by M.R. Ceccarini, M.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!